我们的合作伙伴:
中国地区超过5000个高品质化合物库存
应用领域
GAL-021 is a new intravenous BKCa-channel blocker.
| Cas No.: |
1380341-99-0 |
| 名称: |
|
| 别名: |
GAL021,GAL 021 |
| SMILES: |
CCCNC1=NC(N(OC)C)=NC(NCCC)=N1 |
| 分子式: |
C11H22N6O |
| 分子量: |
254.33 |
| 纯度: |
|
| 保存条件: |
|
| Description: |
|
| In Vivo: |
|
| In Vitro: |
|
| References: |
GAL-021 is a new intravenous BKCa-channel blocker,well tolerated and stimulates ventilation in healthy volunteers. GAL-021 was safe and generally well tolerated with adverse events comparable with placebo except for an infusion site burning sensation. GAL-021 stimulated ventilation at the highest doses suggesting that greater infusion rates may be required for maximum PD effects. GAL-021 had PK characteristics consistent with an acute care medication. |
| Kinase Assay: |
|
| Cell Assay: |
|
| Animal Administration: |
|
| References: |
|
MSDS
COA
| LOT NO. |
DOWNLOAD |
|
|
| 2018-0101 |
|
询盘
